Scientists probe muscle loss in ICU patients with novel tracer technique
NCT ID NCT03451968
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to understand how amino acids are processed differently in critically ill patients who have been in the ICU for more than 7 days compared to healthy volunteers. Researchers will inject stable (non-radioactive) amino acid tracers and take multiple blood samples over 3 hours to measure metabolism. The goal is to gather knowledge that could eventually lead to better nutritional support or treatments to prevent muscle wasting in long-stay ICU patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
stable amino acid tracers (injected)
What this could lead to
If successful, this could help guide future treatments to prevent muscle wasting in long-term ICU patients.
What could go wrong
This is a small, early observational study with only 30 participants. It measures metabolism but does not test any treatment, so direct patient benefits are not expected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLISM AND NUTRITION DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rabin medical center
RECRUITINGPetah Tikva, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••